Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline

Currently, age-related macular degeneration (AMD) is treated while patients exhibit good best-corrected visual acuity (BCVA). However, previous clinical trials only include patients with poor BCVA. We prospectively analyzed the benefits of intravitreal aflibercept (IVA) treatment for AMD patients ex...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Minami, Sakiko, Nagai, Norihiro, Suzuki, Misa, Kurihara, Toshihide, Sonobe, Hideki, Kamoshita, Mamoru, Uchida, Atsuro, Shinoda, Hajime, Takagi, Hitoshi, Sonoda, Shozo, Sakamoto, Taiji, Tsubota, Kazuo, Ozawa, Yoko
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5758719/
https://ncbi.nlm.nih.gov/pubmed/29311612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-18255-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars